Market revenue in 2023 | USD 28.4 million |
Market revenue in 2030 | USD 38.5 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Mammalian source |
Fastest growing segment | Mammalian Source |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Microbial Source, Mammalian Source, Other Source |
Key market players worldwide | WuXi Biologics (Cayman) Inc, FUJIFILM Holdings Corp, AGC Biologics, Thermo Fisher Scientific Inc, Curia, Genscript Biotech Corp Class H, Boehringer Ingelheim Pharma, Abzena, JSR Corp, Bionova Scientific |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract development market will help companies and investors design strategic landscapes.
Mammalian source was the largest segment with a revenue share of 52.11% in 2023. Horizon Databook has segmented the UAE biologics contract development market based on microbial source, mammalian source, other source covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE has the worlds most advanced medical technologies with government funded comprehensive health services. In 2018, number of patent applications in the UAE was 56. Although number of patent applications fluctuated substantially in the past, it positioned to increase from 2011 to 2018, and there we a total of 56 pataent applications by the end of2018.
Many of the new CROs and CDMOs with presence outside the gulf region are now making their entry to the UAE to collaborate with some older pre-existing outsourcing organizations, which are already benefitting from being the first players in this region.
Increase in life sciences companies and outsourcing of various functions is driving the market growth. Cities like Dubai are quickly becoming international hubs for the global healthcare industry. It is already home to the world’s largest medical free zone called Dubai Healthcare City. All these factors are likely boost the market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE biologics contract development market, including forecasts for subscribers. This country databook contains high-level insights into UAE biologics contract development market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account